Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

google.com

Google Alert - relay therapeutics

Get the latest updates from Google Alert - relay therapeutics directly as they happen.

Follow now 146 followers

Latest posts

Last updated about 6 hours ago

Tower Research Capital LLC TRC Acquires 3,549 Shares of Structure Therapeutics Inc ...

about 15 hours ago

... Therapeutics Inc. (NASDAQ:GPCR) at The AM Reporter. ... « PREVIOUS HEADLINE...

Analysts Offer Insights on Healthcare Companies: BioAtla (BCAB), Relay Therapeutics ...

about 23 hours ago

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and...

Relay Therapeutics to Participate in Two Upcoming Investor Conferences - Enidnews.com

1 day ago

CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq...

Hub Group Reports First Quarter 2025 Results | The Manila Times

1 day ago

Relay Therapeutics to Participate in Two Upcoming Investor Conferences. Today in Headlines...

Barclays Forecasts Strong Price Appreciation for Datadog (NASDAQ:DDOG) Stock

1 day ago

MetLife Investment Management LLC Grows Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY). You...

Gilead Sciences to invest $11 billion in U.S. R&D and manufacturing - Yahoo Finance

2 days ago

Relay Therapeutics, Inc. (RLAY)'s share was trading at $3.15 as of May...

Relay Therapeutics, Inc. (RLAY): A Bull Case Theory - Yahoo Finance

2 days ago

We came across a bullish thesis on Relay Therapeutics, Inc. (RLAY) on...

Relay Therapeutics price target lowered to $10 from $30 at Guggenheim - TipRanks.com

2 days ago

Guggenheim lowered the firm's price target on Relay Therapeutics (RLAY) to $10...

Guggenheim Lowers Price Target for Relay Therapeutics (RLAY) to $10.00 - GuruFocus

2 days ago

On May 7, 2025, Guggenheim analyst Michael Schmidt maintained a "Buy" rating...

Relay Therapeutics (RLAY) Stock Target Reduced Amid Strategic Changes and Progress

2 days ago

Guggenheim has revised its price target for Relay Therapeutics (RLAY), dropping it...

Relay Therapeutics Extends Cash Runway and Advances Clinical Trials - TipRanks.com

3 days ago

Relay Therapeutics Inc ( ($RLAY) ) has released its Q1 earnings. Here...

Awaiting Significant Catalysts Amidst Strong Cash Position and Pipeline Potential - TipRanks

4 days ago

Eva Fortea Verdejo's rating is based on the current lack of significant...